Related by context. All words. (Click for frequent words.) 75 colorectal adenoma 72 advanced adenoma 71 colorectal neoplasia 71 prostate cancer CaP 70 endometrial hyperplasia 69 advanced adenomas 69 adenoma 68 polyp recurrence 68 coronary calcification 68 oesophageal adenocarcinoma 68 endometrial cancers 68 adenomatous polyps 68 venous thrombosis 68 advanced neoplasia 68 neurodevelopmental outcome 67 adenoma recurrence 67 recurrent VTE 67 dysglycemia 67 recurrent venous thromboembolism 67 adenomas 67 tibolone 67 postmenopausal breast cancer 67 nonmelanoma skin cancer 67 distal colon cancer 67 SRBD 67 postoperative AF 66 gallstone disease 66 colorectal neoplasms 66 endometrial carcinoma 66 esophageal adenocarcinoma 66 selenium supplementation 66 hyperhomocysteinemia 66 intravenous bisphosphonates 66 atypical hyperplasia 66 microbleeds 66 colorectal carcinoma 66 lobular carcinoma 66 highest quintile 66 postmenopausal hormone 66 thromboembolic 66 metachronous 66 CVD mortality 66 HNSCC 66 colorectal polyps 65 MGUS 65 lobular breast cancer 65 nonmelanoma skin cancers 65 folate deficiency 65 spontaneous preterm delivery 65 cardiovascular mortality 65 endometriosis ovarian cysts 65 thromboembolic events 65 pCR 65 lobular cancer 65 NP CRNs 65 plasma folate 65 colon polyps 65 histologic subtype 65 serum folate concentrations 65 beta carotene supplementation 65 colorectal tumors 65 colorectal cancer 65 TT genotype 65 colorectal cancer CRC 65 CHD mortality 65 spontaneous preterm birth 65 atypical ductal hyperplasia 65 osteosarcomas 65 premenopausal breast cancer 65 thromboembolism 65 β blockers 65 mammographic density 65 arterial thickening 65 lipid lowering medications 64 neoplasia 64 TEAEs 64 urolithiasis 64 thrombotic events 64 diverticular bleeding 64 serous ovarian cancer 64 NAT2 64 cerebral microbleeds 64 Prostatitis 64 ductal carcinomas 64 serum PSA 64 thromboembolic disease 64 subclinical atherosclerosis 64 transferrin saturation 64 atopic disease 64 serum BDNF 64 carotid IMT 64 lignan intake 64 gastric cardia 64 subclinical hyperthyroidism 64 BRCA2 mutation carriers 64 benign breast 64 hormone therapy estrogen 64 invasive ductal 64 atypia 64 extrapyramidal symptoms 64 endometrial cancer 64 deep venous thromboses 64 ductal cancer 64 HGPIN 64 intestinal polyps 64 HIV HCV coinfected 64 abnormal lipid 64 proliferative diabetic retinopathy 64 breast endometrial 64 nonfatal MI 64 thyrotropin levels 64 venous blood clots 64 serum homocysteine 64 esophageal squamous cell carcinoma 64 NNRTI resistance 64 nonvertebral fractures 64 colorectal polyp 64 atrophic gastritis 64 node metastases 64 de ath 64 BRCA1 mutation carriers 64 liver metastasis 64 thiazide diuretics 64 NMIBC 64 biochemical recurrence 64 leiomyomas 64 hematopoietic cancers 63 carotid atherosclerosis 63 ABCB1 63 perimenopausal women 63 relapsed MM 63 hypoglycaemic episodes 63 malignant polyps 63 mg BID dose 63 chlamydial infection 63 subclinical hypothyroidism 63 postoperative delirium 63 Helicobacter pylori infection 63 haemorrhagic stroke 63 Adenomas 63 Erythropoietic therapies may 63 prolonged QT interval 63 hip BMD 63 undergone radical prostatectomy 63 basal cell nevus syndrome 63 bowel polyps 63 bilateral oophorectomy 63 NHANES III 63 axillary node 63 amenorrhoea 63 precancerous colon polyps 63 CIN3 63 myocardial ischemia 63 cervical lesions 63 antioxidant supplementation 63 confidence interval #.#-#.# 63 CC genotype 63 APOE e4 63 pathologic fractures 63 gastric adenocarcinoma 63 definite stent thrombosis 63 cerebral infarction 63 invasive carcinomas 63 abdominal adiposity 63 carotid plaque 63 reinfarction 63 urate levels 63 CIN2 + 63 nonalcoholic steatohepatitis NASH 63 paclitaxel eluting stents 63 shorter telomere length 63 flutamide 63 folate intake 63 postmenopausal hormone replacement 63 aspirin NSAIDs 63 distant metastasis 63 diabetes mellitus DM 63 uveal melanoma 63 MetS 63 VaD 63 serum uric acid 63 cardioembolic stroke 63 NAFLD 63 carotid stenosis 63 nonmetastatic 63 rs# [004] 63 testicular tumors 63 coronary artery calcification 63 venous thromboembolism 63 HER2 overexpression 63 fasting glucose levels 63 highest tertile 63 arterial calcification 63 LRP5 63 urothelial cancer 63 myocardial infarction MI 63 OSAHS 63 serum estradiol 63 thyroid carcinoma 63 vertebral fracture 63 invasive carcinoma 62 micrometastases 62 BRCA2 mutations 62 non aspirin NSAIDs 62 specific antigen PSA 62 serum phosphate 62 adenomatous 62 androgen suppression 62 uterine cancers 62 telomere lengths 62 variceal bleeding 62 clinically detectable 62 familial clustering 62 preterm delivery 62 recurrent DVT 62 plasma selenium 62 HBV infection 62 hypercholesterolaemia 62 colon adenomas 62 estrogen progestin therapy 62 postoperative mortality 62 invasive breast cancer 62 severe periodontitis 62 nonalcoholic steatohepatitis 62 renal cell carcinomas 62 precancerous cervical 62 thyroid dysfunction 62 serum urate levels 62 thiopurine 62 biochemical relapse 62 PCa 62 estrogen receptor negative 62 familial pancreatic cancer 62 androgen deprivation 62 serum folate 62 N telopeptide 62 intestinal permeability 62 contralateral breast cancer 62 oxcarbazepine 62 chronic periodontitis 62 octreotide LAR 62 Sjögren syndrome 62 breast carcinoma 62 serum retinol 62 hepatic steatosis 62 distant metastases 62 GISTs 62 risedronate Actonel 62 calcium supplementation 62 tHcy 62 nonfasting triglyceride levels 62 macrovascular 62 cervical intraepithelial neoplasia 62 prostate carcinogenesis 62 venous thromboembolic disease 62 HER2 expression 62 T1DM 62 vitamin D inadequacy 62 PSADT 62 anovulatory infertility 62 rs# [002] 62 vasomotor symptoms 62 Calcium intake 62 salmeterol HFA MDI 62 osteoclastic 62 comorbid depression 62 artery calcification 62 APOL1 62 macrovascular events 62 atherogenic dyslipidemia 62 fetal chromosomal 62 serum parathyroid hormone 62 testicular germ cell 62 colonic polyps 62 thromboembolic disorders 62 rosuvastatin Crestor 62 CMV infection 62 CP CPPS 62 bronchopulmonary dysplasia 62 acute myocardial infarctions 62 TP# mutations 62 recurrent atrial fibrillation 62 serum vitamin D 62 arterial thromboembolic events 62 autonomic dysfunction 62 histological subtype 62 syncopal 62 chronic prostatitis 62 cryptorchidism 62 macroalbuminuria 62 serum selenium 62 LV dysfunction 62 conjugated equine estrogen 62 hemorrhagic complications 62 cutaneous melanoma 62 multivariate adjustment 61 silent ischemia 61 breast cancer recurrence 61 asymptomatic carotid stenosis 61 ticlopidine 61 perioperative mortality 61 impaired glucose metabolism 61 serum leptin 61 finasteride Proscar 61 nonfasting triglycerides 61 habitual snoring 61 carotid plaques 61 BRCA1 mutations 61 cervical carcinoma 61 pharyngeal cancer 61 atherothrombotic disease 61 epithelial tumors 61 T2 lesions 61 plasma lipid 61 serum lipid levels 61 hypoglycemic episodes 61 HMG CoA reductase inhibitors 61 cranial irradiation 61 Arch Intern Med 61 hypercalciuria 61 Postoperative complications 61 recurrent UTI 61 onset diabetes mellitus 61 hypovitaminosis D 61 prostate cancer PCa 61 HeFH 61 PTPN# 61 urothelial carcinoma 61 EpCAM expression 61 intracerebral hemorrhage 61 lung metastasis 61 nonaspirin 61 SGPT 61 recurrent glioblastoma multiforme 61 left ventricular dysfunction 61 myopathy rhabdomyolysis 61 PSA nadir 61 myocardial infarctions MIs 61 HBeAg 61 neoplasias 61 GnRH agonists 61 postoperative pulmonary 61 parous women 61 undergoing radical prostatectomy 61 bladder cancers 61 esophageal cancers 61 microvascular complications 61 venlafaxine Effexor 61 folic acid intake 61 #p#.# [002] 61 primary hyperparathyroidism 61 Nonalcoholic Fatty Liver Disease 61 upper gastrointestinal bleeding 61 carotid artery thickness 61 atherosclerotic vascular disease 61 overt nephropathy 61 lowest tertile 61 grade cervical intraepithelial 61 left ventricular systolic 61 BRCA mutation carriers 61 pancreatic prostate 61 atherosclerotic progression 61 albumin excretion rate 61 lipid parameters 61 p# mutations 61 pre menopausal 61 plasma adiponectin 61 MGd 61 clinicopathological 61 prenatal exposures 61 flavonoid intake 61 COX2 61 dietary calcium intake 61 paricalcitol 61 retrospective cohort 61 periprocedural MI 61 epithelial ovarian cancer 61 urinary calcium 61 Genetic variants 61 colon tumors 61 ADPKD 61 renal toxicity 61 vulvovaginal atrophy 61 QTc interval 61 tumor recurrence 61 plasma homocysteine levels 61 hepatic fibrosis 61 precursor lesions 61 rectal cancers 61 INTERHEART study 61 tumor histology 61 locoregional recurrence 61 thromboembolic complications 61 hamartomas 61 severe neutropenia 61 Asymptomatic 61 Subgroup analyzes 61 neurocognitive function 61 elevated triglyceride levels 61 papillary renal cell carcinoma 61 overt hepatic encephalopathy HE 61 contrast induced nephropathy 61 familial AF 61 torsade de pointes 61 nonpregnant women 61 ovarian hormones 61 Framingham Offspring Study 61 #OHD levels 61 dietary fiber intake 61 aminotransferase ALT 61 #.#ng/ml 61 atherothrombotic events 61 bone metastasis 61 neuropsychiatric symptoms 61 hydroxyvitamin D levels 61 androgen deficiency 61 invasive lobular 61 serum triglycerides 61 PSA kinetics 61 rs# [003] 61 hsCRP levels 61 conjugated estrogen 61 hypercalcemia 61 neoplasm 61 salmeterol fluticasone propionate 61 inflammatory polyarthritis 61 nonischemic 61 depressive symptomatology 61 abnormal glucose tolerance 61 endogenous estrogen 61 adenocarcinomas 61 CaP 61 normotensive 61 troponin T 61 microvascular disease 61 Kaplan Meier analysis 61 esophageal carcinoma 61 adiponectin levels 61 TMP SMX 61 parkinsonian symptoms 61 prednisone prednisolone 61 neoplasms 60 endometrial 60 tamsulosin 60 KIF6 carriers 60 FGFR2 gene 60 mycophenolate mofetil 60 aminotransferases 60 amnestic mild cognitive impairment 60 osteoporotic fracture 60 nodal metastasis 60 corticosteroid therapy 60 gastric carcinoma 60 Hashimoto thyroiditis 60 albuminuria 60 Uterine cancer 60 Chlamydia trachomatis infection 60 antiandrogen 60 mammary tumors 60 noncardiac 60 protein excretion 60 Wactawski Wende 60 gene APOE 60 sustained ventricular tachycardia 60 chorioamnionitis 60 folate supplementation 60 serum concentrations 60 postoperative atrial fibrillation 60 venous thromboembolic events 60 DQB1 * 60 prostate carcinoma 60 euthyroid 60 squamous cell lung cancer 60 serum creatinine levels 60 hepatic enzymes 60 H. pylori infection 60 magnesium intake 60 rs# [001] 60 RLS symptoms 60 GSTT1 60 coronary stenosis 60 neurodevelopmental outcomes 60 univariate analyzes 60 beta blocker therapy 60 premenstrual syndrome PMS 60 pelvic lymphadenectomy 60 complete cytogenetic response 60 hyperplastic polyps 60 apolipoprotein E4 60 endometrial thickness 60 thrombocytopenic 60 untreated celiac disease 60 atherothrombosis 60 periodontitis 60 androgen ablation 60 psychiatric morbidity 60 non valvular atrial 60 VTEs 60 elevated ALT 60 Folate deficiency 60 serum PTH 60 elevated CRP 60 cilostazol 60 intima media thickness 60 ductal breast cancer 60 symptomatic VTE 60 postoperative complication 60 mucinous 60 ximelagatran 60 nonvertebral fracture 60 postmenopausal hormones 60 hepatic enzyme 60 Leydig cell 60 B vitamin supplementation 60 gross hematuria 60 dalteparin 60 ovarian carcinoma 60 dysmenorrhoea 60 SLNB 60 DRB1 * 60 lumbar spine bone 60 CYP#D# inhibitor 60 mesotheliomas 60 neurological abnormalities 60 malignant neoplasm 60 atherosclerotic disease 60 premalignant lesions 60 Venous thromboembolism 60 atypical femur fractures 60 Wisconsin Sleep Cohort 60 nondiabetic 60 fasting insulin 60 platelet activation 60 postoperative complications 60 Cognitive impairment 60 HBV infections 60 APOE ε4 60 GBA mutations 60 thyrotoxicosis 60 coronary artery calcium 60 gestational hypertension 60 IGFBP 60 breast cancer recurrences 60 nodal metastases 60 prostate adenocarcinoma 60 cyclooxygenase 2 60 recurrent acute pancreatitis 60 gestational diabetes mellitus GDM 60 antihypertensive therapy 60 antiphospholipid antibodies 60 bladder tumors 60 pulmonary toxicity 60 GSTM1 60 white matter hyperintensities 60 incontinence episodes 60 plus medroxyprogesterone acetate 60 PLX STROKE targeting 60 mesangial 60 lipid lowering drugs 60 dietary folate intake 60 SHBG levels 60 creatinine ratio 60 multivariable analysis 60 Insulin sensitivity 60 clinically insignificant 60 inflammatory biomarkers 60 serum IGF 60 affective psychosis 60 paroxetine Paxil 60 situ LCIS 60 colorectal cancer incidence 60 affective psychoses 60 G allele 60 skeletal metastases 60 ischemic stroke 60 leucopenia 60 lymphovascular invasion 60 acute GVHD 60 poor metabolizers 60 Lp PLA 2 60 PRADAXA #mg 60 Heavy menstrual bleeding 60 epithelial ovarian 60 Doxil ® 60 plasma homocysteine 60 ovarian pancreatic 60 amyloid deposition 60 torsades de pointes 60 chromosomal aberrations 60 elevated homocysteine 60 osteoporotic fractures 60 p = #.# [003] 60 pheochromocytomas 60 oxycodone CR 60 seminoma 60 anti androgen 60 asthma exacerbation 60 fetal malformations 60 intact parathyroid hormone 60 colorectal cancers 60 Rectal cancer 60 myeloperoxidase 60 asymptomatic PAD 60 CYP#C# [001] 60 CIMZIA ™ 60 premenopausal 60 cobiprostone 60 femoral neck BMD 60 Hepatotoxicity 60 venous thromboembolism VTE 60 triglyceride concentrations 60 glycated hemoglobin levels 60 B7 H3 60 noncarriers 60 cardiac repolarization 60 citalopram Celexa 60 TNF blocker therapy 60 hematologic toxicity 60 triacylglycerol concentrations 60 Epidemiological studies 60 mL/min/#.# m 2 59 ischemic strokes 59 NSAID induced 59 prospective observational studies 59 SERMs 59 systolic dysfunction 59 irregular menstrual cycles 59 atopy 59 radical prostatectomy RP 59 β blocker 59 leukaemias 59 GSTP1 59 Myocardial infarction 59 Epidemiologic studies 59 EXJADE 59 lumbar disk herniation 59 nondemented 59 IPAH 59 BRCA mutations 59 amenorrhea 59 GH deficiency 59 GSTM1 gene 59 homocysteine concentrations 59 hypophosphatemia 59 carotid intima media 59 paroxysmal AF 59 PAOD 59 Papillary 59 CMV disease 59 tamoxifen Nolvadex ® 59 dopaminergic therapy 59 cardiac dysfunction 59 gestational diabetes mellitus 59 neuropathological 59 macrovascular disease 59 perioperative complications 59 carcinoid tumor 59 ibandronate 59 BRAF V#E 59 STRIDE PD 59 serum aminotransferase levels 59 HbF 59 containing drospirenone 59 pharyngeal cancers 59 achieved ACR# 59 tertile 59 COPD exacerbations 59 PHPT 59 mTOR inhibitors 59 extracapsular extension 59 oropharyngeal cancer 59 prothrombotic 59 glomerular filtration 59 postmenopausal hormone therapy 59 oral antidiabetic medication 59 SIBO 59 antidiabetic medication 59 lichen planus 59 H. pylori eradication 59 immunosuppressant therapy 59 lymphocytosis 59 transfusion syndrome 59 Serious adverse reactions 59 subtrochanteric 59 F FDG PET 59 % CI #.#-#.# [003] 59 BCR ABL mutations 59 oral antidiabetic drugs 59 #q# [001] 59 SUVmax 59 Thalomid ® 59 VUR 59 Digital Mammographic Imaging 59 CLA supplementation 59 C1 INH deficiency 59 APOE e4 allele 59 thrombotic complications 59 Febrile neutropenia 59 deferiprone 59 squamous cell cancers 59 retinal vein occlusion 59 mucosal lesions 59 corticosteroid dose 59 clinicopathologic 59 morphometric vertebral fractures 59 antigen PSA 59 AML MDS 59 testosterone supplementation 59 G6PD deficiency 59 infarcts 59 alcoholic cirrhosis 59 CHD CVD 59 progesterone receptor negative 59 cardiovascular disease 59 colorectal carcinogenesis 59 venous thromboembolisms 59 cerebrovascular events 59 Adjuvant chemotherapy 59 clodronate 59 metastatic GIST 59 Celecoxib APC trial 59 alanine aminotransferase 59 disease NAFLD 59 necrotic core 59 #q# deletion 59 posaconazole 59 rebleeding 59 aromatase inhibitor therapy 59 thyroid hormone levels 59 hepatocellular carcinoma HCC 59 stone formers 59 LQTS 59 external genital lesions 59 nonvaccine 59 familial aggregation 59 axillary lymph nodes 59 hemorrhagic strokes 59 oral bisphosphonate 59 Hematologic 59 benign noncancerous 59 postintervention 59 transdermal estrogen 59 intravascular hemolysis 59 Non Alcoholic Fatty 59 MMSE scores 59 urinary oxalate 59 basal cell carcinomas 59 neurocognitive functioning 59 elevated LDL cholesterol 59 ALT elevation 59 microdeletions 59 Chronic pancreatitis 59 albumin excretion 59 preterm deliveries 59 digestive tract cancers 59 MLH1 59 alanine aminotransferase ALT 59 postmenopausal women 59 Subgroup analysis 59 intracerebral 59 APTIVUS r 59 proximal colon 59 cTnT 59 ventricular tachyarrhythmia 59 elevated triglycerides 59 XIENCE V demonstrated 59 Hilakivi Clarke 59 seropositivity 59 Soy isoflavones 59 colon rectal 59 T1c 59 alfuzosin 59 Invasive Breast Cancer 59 Hypotension 59 TOP2A gene 59 neurocognitive deficits 59 intraventricular hemorrhage 59 neoplasia PIN 59 thromboses 59 cardio vascular disease 59 HNPCC 59 NIDDM 59 malignant lymphoma 59 anemia hemoglobin 59 recurrent myocardial infarction 59 cholelithiasis 59 hydroxyvitamin D concentrations 59 mucosal inflammation 59 alcoholic fatty liver 59 psychiatric comorbidities 59 nondiabetic patients 59 neovascular AMD 59 gene polymorphism 59 pre eclamptic 59 azoospermia 59 nonselective NSAIDs 59 gefitinib Iressa 59 lipid lowering agents 59 myocardial infarctions 59 cardiovascular disease CVD 59 probiotic supplementation 59 folic acid supplementation 59 overt hypothyroidism 59 MTHFR 59 idiopathic PAH 59 eosinophil count 59 phylloquinone 59 polycystic ovary syndrome PCOS 59 #mg/day [001] 59 antiandrogens 59 acromegalic patients 59 neurocognitive impairment 59 parasitemia 59 systemic lupus erythematosus SLE 59 androgen excess 59 potassium sparing diuretics 59 lactate dehydrogenase 59 anogenital 59 Relapsing remitting MS 59 hormone receptor negative 59 receiving VELCADE 59 EEG abnormalities 59 oophorectomy 59 anthracycline taxane 59 haloperidol Haldol 59 cardiorespiratory fitness 59 CIN3 + 59 oral FTY# 59 estramustine 59 nucleoside analogues 59 hypermethylated 59 keloid scarring 59 placental malaria 59 bexarotene 59 vitamin B# deficiency 59 endometrial kidney 59 LDL cholesterol concentrations 59 atheroma volume 59 hepatocellular 59 pT3 59 urothelial 59 unstable angina pectoris 59 choriocarcinoma 59 microalbuminuria 59 Hazard Ratio HR 59 MMSE score 59 axillary node dissection 59 ertapenem 59 hippocampal volume 59 HBeAg negative patients 59 femoral neck fracture 59 preoperative PSA 59 hydroxychloroquine 59 ATACAND 59 serum cortisol 59 selenium intake 59 neurologic complications 59 aged ≥ 59 NPH insulin 59 TCF#L# 59 hippocampal atrophy 59 renal dysfunction 59 EBV infection 59 P = .# 59 FGFR2 59 ductal adenocarcinoma 59 CYT# potent vascular disrupting 59 aromatase inhibitors AIs 59 varicocele 59 aldosterone antagonists 59 cognitively normal 59 genital herpes infections 59 meta regression 59 MAGE A3 ASCI 59 ASCUS 59 NOLVADEX 59 vascular dysfunction 59 ERalpha 59 hypoglycemic events 59 HbA 1c levels 59 cancerdefine 59 malignant neoplasms 59 Multiethnic Study 59 ULORIC 59 bacteriuria 59 UGT#A# * 59 nonobese 59 cardio metabolic 59 onset atrial fibrillation 59 hypoperfusion 59 Radical prostatectomy 59 atopic 59 colorectal bowel 59 perioperative morbidity 59 intensive statin therapy 59 ipsilateral stroke 59 Carotid Revascularization Endarterectomy vs. 59 orofacial clefts 59 2 diabetes T2D 59 monoclonal gammopathy 59 ischemic lesions 59 precancerous lesions 59 E selectin 59 FluCAM arm 59 choroidal neovascularization 59 paraganglioma 59 serum lipids 59 Proteinuria 58 aneurysmal subarachnoid hemorrhage 58 predisposing factor 58 #q# deletion syndrome 58 pharmacologic treatments 58 Alzheimer Disease AD 58 attain statistical significance 58 nonproliferative 58 corrected QT interval 58 inherited mutations 58 CDI recurrence 58 recurrent ischemia 58 vitamin K1 58 lymph node metastases 58 lesional 58 cerebral vasospasm 58 hepatorenal syndrome 58 obese postmenopausal 58 gouty arthritis 58 subclinical disease 58 GERD symptoms 58 fluvastatin 58 Androgen deprivation therapy 58 recurrent metastatic 58 anterior uveitis 58 insulin resistance syndrome 58 angiotensin converting enzyme inhibitors 58 cardioprotective effects 58 lung carcinomas 58 COPD exacerbation 58 intraoperative complications 58 nondepressed 58 K ras mutations 58 kaempferol 58 metabolic disturbances 58 elevated depressive symptoms 58 distal colon 58 elevated LDH 58 5-FU/LV 58 endogenous hormones 58 prostate ovarian 58 premenopause 58 APOE genotype 58 microsatellite instability 58 Menopausal hormone therapy 58 stratifying patients 58 Swedish Mammography Cohort 58 IDDM 58 LUTS 58 malignant growths 58 Barrett esophagus BE 58 intravesical therapy 58 serum GGT 58 serum urate 58 intracranial stenosis 58 neoplastic lesions 58 bladder carcinoma 58 severe hypersensitivity reactions 58 esophagus bladder 58 progressive dyspnea 58 clinicopathological features 58 Osteoporotic Fractures 58 antibody titer 58 candesartan cilexetil 58 fasting triglyceride levels 58 thromboembolisms 58 recurrent miscarriage 58 neuronal dysfunction 58 cerivastatin 58 serum prostate 58 prognostic indicators 58 PGDH 58 kidney urologic 58 lifetime abstainers 58 obstructive coronary artery 58 #p# [001] 58 dyslipidaemia 58 oesophageal squamous cell carcinoma 58 tiagabine 58 serum markers 58 perineural invasion 58 olmesartan 58 germline mutations 58 intracranial hemorrhage ICH 58 laryngeal cancers 58 lupus anticoagulant 58 uterine tumors 58 Faslodex 58 venous thromboembolic 58 acrylamide intake 58 nocturnal hypoglycaemia 58 Tardive dyskinesia